- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Sichuan Cancer Hospital & Institute
I alt 3903 resultater
-
Peking University Cancer Hospital & InstituteRekrutteringLaparoskopisk kirurgi | Mavekræft | Gastrectomi | LymfadenektomiKina
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnu
-
Shandong Cancer Hospital and InstituteRekrutteringBrystkræft i tidligt stadie | Brystbevarende kirurgiKina
-
Peking University Cancer Hospital & InstituteAfsluttetKræftpatienter | FunktionsforlængelseKina
-
Shandong Cancer Hospital and InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterendeKræftrelateret problem/tilstandKina
-
Peking University Cancer Hospital & InstituteAfsluttetMetastatisk lungekræftKina
-
Peking University Cancer Hospital & InstituteAfsluttetSpiserørskræftKina
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteUkendtMR scanning | Positron-emissionstomografiKina
-
Shandong Cancer Hospital and InstituteUkendtBrystkræft | HER2-positiv brystkræftKina
-
Peking University Cancer Hospital & InstituteUkendtHepatocellulært karcinom | Transarteriel kemoembolisering
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendt
-
Shandong Cancer Hospital and InstituteAfsluttetEsophageale neoplasmerKina
-
Shandong Cancer Hospital and InstituteUkendtAvanceret kræft | Strålingstoksicitet | RadiosensitivitetKina
-
Shandong Cancer Hospital and InstituteUkendtTilbagevendende glioblastomKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Shandong Cancer Hospital and InstituteUkendtSentinel lymfeknudebiopsiKina
-
Peking University Cancer Hospital & InstituteAfsluttetKræftrelateret problem/tilstand
-
Shandong Cancer Hospital and InstituteUkendtKarcinom, ikke-småcellet lungeKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtMavekræft | Gastroøsofageal cancer
-
Peking University Cancer Hospital & InstituteUkendtNeoplasmer i leverenKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinale neoplasmerKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtLymfom, stor B-celle, diffusKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinal stromal tumorKina
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma Metastase | Immunterapi | GenekspressionsprofileringKina
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinale neoplasmerKina
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma MetastaseKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendt
-
Sichuan Cancer Hospital and Research InstituteFirst Affiliated Hospital Xi'an Jiaotong University; General Hospital of... og andre samarbejdspartnereUkendtLokalt avanceret esophageal pladecellecarcinomKina
-
Shandong Cancer Hospital and InstituteRekrutteringSpiserørskræft | Epigallocatechin Gallate | Dysfagi, esophagealKina
-
Peking University Cancer Hospital & InstituteRekrutteringRecidiverende/refraktær B-celle non-Hodgkin lymfomKina
-
Shandong Cancer Hospital and InstituteRekrutteringNeoadjuverende terapi | Resecerbart ikke-småcellet lungekarcinom | IMMUNOTERAPI | Biomarkører / BlodKina
-
Peking University Cancer Hospital & InstituteRekrutteringKræft i fordøjelsessystemetKina
-
Shandong Cancer Hospital and InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMetastatisk kastrationsresistent prostatakræft
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringFase 2-undersøgelse af SBRT Plus Tislelizumab og Regorafenib i uoperabelt eller oligometastatisk HCCIkke-operabelt hepatocellulært karcinom | Oligometastatisk sygdomKina